Analytical Data
-
Gene name
Agc1
- Application
-
Alternative Names
SLC25A12; ARALAR1; Solute Carrier Family 25 Member 12,Mitochondrial Carrier,Aralar; Calcium-binding mitochondrial carrier protein Aralar1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75746
-
Expression Region
Thr7~Asp245
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AGC1, or amino acid gamma-carboxylic acid decarboxylase 1, is a crucial enzyme involved in the metabolism of amino acids, particularly in the synthesis of neurotransmitters. Research on AGC1 has gained attention due to its potential implications in neurobiology and pharmacology, particularly concerning neurological disorders. Mutations or dysregulation of AGC1 have been linked to various conditions, including mood disorders, schizophrenia, and neurodegenerative diseases. Understanding the structure and function of AGC1 through recombinant protein studies can provide insights into its role in cellular signaling pathways and metabolic processes. Additionally, the development of AGC1 recombinant proteins enables the exploration of its enzymatic mechanisms and interactions with other biomolecules. This knowledge is essential for the identification of potential therapeutic targets and the design of novel treatment strategies aimed at modulating AGC1 activity. Furthermore, research utilizing AGC1 recombinant proteins can lay the groundwork for studying the effects of pharmacological agents on AGC1 function, thereby contributing to a deeper understanding of its contribution to human health and disease. Overall, the investigation of AGC1 recombinant proteins represents a promising avenue for advancing our comprehension of amino acid metabolism and its broader implications in the field of neuroscience and medicine.
